The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Adverse drug reactions in childhood: a review of prospective studies and safety alerts
Abstract
OBJECTIVE: To assess the incidence of adverse drug reactions (ADRs) in the paediatric population and the safety alerts concerning children and adolescents issued by international drug regulatory agencies since 2001. METHODS: A bibliographic search was performed in the Medline and Embase databases for prospective studies published between January 2001 and December 2007 evaluating the ADR incidence in the paediatric population. Data were analysed by a random effect model. Moreover, the websites of nine international drug regulatory agencies were searched to collect information on safety alerts concerning the paediatric population. RESULTS: A total of eight prospective studies were evaluated, six of which concerned the ADR incidence in hospitalised children. The overall incidence of ADRs was 10.9% (95% CI 4.8 to 17.0) in hospitalised children and 1.0% (95% CI 0.3 to 1.7) in outpatient children. The rate of hospital admission due to ADRs was 1.8% (95% CI 0.4 to 3.2). The skin and gastrointestinal system were the organs most commonly affected and antibiotics were the drugs most commonly associated with ADRs. Safety alerts in the paediatric population were retrieved for 28 drugs, five of which were for psychotropic drugs and most of which were issued by the Food and Drug Administration (20 drugs). For 12 drugs, warnings were published in the 2006-2007 period. Antidepressants were the only drugs for which alerts were issued by all the drug regulatory agencies. CONCLUSIONS: To ensure safe and effective medicines for children, efforts are needed at different levels (governments, drug regulatory agencies, pharmaceutical industries, health care professionals, and parents). Collaborative regulatory initiatives, such as the use of common warnings, can also contribute to a more rational use of drugs for children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nasal decongestants for the common cold
Taverner, D., & Latte, G. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001953.pub3 · Cited by 134
RetractedIncidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
A literature review on off-label drug use in children
Pandolfini, C., & Bonati, M. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1698-8 · Cited by 346 · cited 1×
“ADRs in hospitalised children Norway(12) 1996 5 579 0–16 CNS (28), gastrointestinal (27), skin (11) Anti-infective agents (9), anti-asthmatics (7), CNS drugs (7) France(17) 1998 0.”
Self-citationOver the counter but no longer under the radar - pediatric cough and cold medications
Sharfstein, J. M., North, M., & Serwint, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmp0707400 · Cited by 158
Cited by
Factors affecting the development of adverse drug reactions (Review article)
Alomar, M. J. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.02.003 · Cited by 484
Epidemiology and risk factors for drug allergy
Thong, B. Y., & Tan, T. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03774.x · Cited by 393
Adverse Drug Reactions in Children—A Systematic Review
Smyth, R. M. D., Gargon, E., Kirkham, J., Cresswell, L., Golder, S., Smyth, R., & Williamson, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0024061 · Cited by 298
Greaves, P. (2012) · Histopathology of Preclinical Toxicity Studies · doi:10.1016/b978-0-444-53856-7.00002-6 · Cited by 5
Metadata
- Authors
- Clavenna, A., & Bonati, M.
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 2009-06-15
- Volume
- 94
- Issue
- 9
- Pages
- 724-728
- ISSN
- 0003-9888 (ISSN-L)
- 1468-2044
- OpenAlex
- W2115361107
- Cited by
- 179
- References
- 4
- FWCI
- 20.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adverse drug reactions in childhood: a review of prospective studies and safety alerts. https://app.cochat.ai/papers/10.1136/adc.2008.154377
- The paper
- Clavenna, A., & Bonati, M. (2009). Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Archives of Disease in Childhood. https://doi.org/10.1136/adc.2008.154377
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.